Does Rallies track congressional trades in MEDP?

Yes. Rallies tracks politician and congressional stock disclosures for MEDP, including reported purchases, sales, dates, owners, and trade amounts when available.

Is MEDP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MEDP. It does not provide personalized investment advice.

MEDP (Medpace Holdings, Inc. Common Stock) Stock Analysis - Politician Trades

Medpace Holdings, Inc. Common Stock (MEDP) is a publicly traded Healthcare sector company. As of May 21, 2026, MEDP trades at $422.00 with a market cap of $12.01B and a P/E ratio of 25.82. MEDP moved +0.51% today. Year to date, MEDP is -28.11%; over the trailing twelve months it is +37.59%. Its 52-week range spans $250.05 to $628.92. Analyst consensus is buy with an average price target of $447.50. Rallies surfaces MEDP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded MEDP stock?

Recent politician trading activity in MEDP includes disclosures from David Taylor, David Taylor, David Taylor, Gilbert Cisneros, and Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

MEDP Key Metrics

Key financial metrics for MEDP
Metric	Value
Price	$422.00
Market Cap	$12.01B
P/E Ratio	25.82
EPS	$16.22
Dividend Yield	0.00%
52-Week High	$628.92
52-Week Low	$250.05
Volume	333.70K
Avg Volume	0
Revenue (TTM)	$2.68B
Net Income	$460.40M
Gross Margin	29.07%

Congressional Trades in MEDP

David Taylor purchase MEDP on Feb 26, 2026 (amount: $15.00K).
David Taylor purchase MEDP on Jan 29, 2026 (amount: $15.00K).
David Taylor sale MEDP on Jan 16, 2026 (amount: $15.00K).
Gilbert Cisneros sale MEDP on Jan 15, 2026 (amount: $50.00K).
Gilbert Cisneros sale MEDP on Oct 9, 2025 (amount: $15.00K).

Latest MEDP News

Medpace climbs as Q1 beat and FY2026 outlook keep buyers active — May 5, 2026
Medpace jumps 4% as traders buy dip after cancellation-driven earnings selloff — Apr 26, 2026
Medpace rebounds after steep post-earnings selloff as investors refocus on Q1 beat — Apr 25, 2026
Medpace rebounds 3% as investors reassess Q1 beat after bookings-driven selloff — Apr 24, 2026
Medpace Q1 Revenue Jumps 26.5% to $706.6M, EBITDA Up 25.9% — Apr 24, 2026

Recent MEDP Insider Trades

GEIGER JESSE J sold 31.71K (~$14.44M) on Mar 17, 2026.
Troendle August J. sold 668 (~$394.58K) on Dec 3, 2025.
Troendle August J. sold 5.70K (~$3.36M) on Dec 2, 2025.

MEDP Analyst Consensus

8 analysts cover MEDP: 0 strong buy, 3 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $447.50.

Common questions about MEDP

Which politicians traded MEDP stock?: Recent politician trading activity in MEDP includes disclosures from David Taylor, David Taylor, David Taylor, Gilbert Cisneros, and Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in MEDP?: Yes. Rallies tracks politician and congressional stock disclosures for MEDP, including reported purchases, sales, dates, owners, and trade amounts when available.
Is MEDP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MEDP. It does not provide personalized investment advice.